Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Time-Based Sampling Schedule – V 2.0

Posted on By

Elixir Department: SOP for Time-Based Sampling Schedule – V 2.0

Standard Operating Procedure for Time-Based Sampling Schedule During Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/204/2025
Supersedes SOP/ELX/204/2022
Page No. Page 1 of 9
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To establish a standardized procedure for implementing and documenting a time-based sampling schedule during the elixir manufacturing process to ensure compliance with Good Manufacturing Practices (GMP) and enable timely process control.

2. Scope

This SOP is applicable to all in-process time-based sampling performed during elixir manufacturing, including sampling for physical, chemical, and microbiological testing at defined intervals.

3. Responsibilities

  • Production Operator:
    • Ensure timely coordination and accessibility for sample collection.
  • QC Analyst:
    • Collect, label, and test samples as per schedule.
    • Maintain accurate records of sampling times and results.
  • QA Officer:
    • Verify sampling adherence and review results for compliance.

See also  Elixir Department: SOP for Line Clearance After Manufacturing - V 2.0

4. Accountability

The QC Head is accountable for execution and accuracy of the schedule. The Production Head ensures sampling access. QA ensures documentation integrity and regulatory compliance.

5. Procedure

5.1 Establishment of Sampling Schedule

  1. Prepare a
sampling plan during batch planning based on:
  • Critical process steps (e.g., mixing, dissolution, heating, cooling)
  • Process duration
  • Regulatory and internal quality requirements
  • Define exact sampling intervals (e.g., every 15 min, 30 min, 1 hour) and sample types.
  • Document in the Time-Based Sampling Schedule Sheet (Annexure-1) and attach to BMR.
  • 5.2 Sampling Execution

    1. Collect samples at predefined times using clean and labeled containers.
    2. Sampling must be carried out in the order listed in the schedule.
    3. Label each sample with:
      • Product name
      • Batch number
      • Sampling time
      • Sampling point
      • Type of test (e.g., pH, assay, microbial)
    4. Immediately transfer samples to the QC laboratory under appropriate conditions (e.g., temperature).

    5.3 Testing and Evaluation

    1. Analyze samples for:
      • pH
      • API content
      • Appearance and clarity
      • Conductivity
      • Microbial limits (as applicable)
    2. Record test results against each time point in the logbook.
    3. Any deviation or trend indicating instability or abnormality must be reported immediately to QA and Production.

    5.4 Deviation Handling

    1. Missed or delayed sampling must be documented with justification.
    2. Initiate deviation report if sampling is missed or time exceeded by more than ±10% of the scheduled time.

    5.5 Documentation

    1. Maintain a Time-Based Sampling Logbook (Annexure-2) for each batch.
    2. Attach analytical data and QA review sheets to the BMR.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • QA: Quality Assurance
    • QC: Quality Control
    • BMR: Batch Manufacturing Record
    • API: Active Pharmaceutical Ingredient

    7. Documents

    1. Time-Based Sampling Schedule Sheet (Annexure-1)
    2. Time-Based Sampling Logbook (Annexure-2)
    3. Batch Manufacturing Record (BMR)

    8. References

    • ICH Q8 – Pharmaceutical Development
    • 21 CFR Part 211.110 – In-Process Sampling and Testing
    • WHO TRS 986 – Annex 2: GMP for Pharmaceutical Products

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Time-Based Sampling Schedule Sheet

    Sampling Time Test Location Sample Collected By QC Received Time Remarks
    10:00 AM pH Mixing Tank Rajesh Kumar 10:15 AM Within range

    Annexure-2: Time-Based Sampling Logbook

    Date Batch No. Sampling Point Test Performed Result Tested By QA Verified
    11/04/2025 ELX-0425-023 Middle Layer API Assay 98.6% Sunita Reddy Manoj Sharma

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial Release New SOP QA Head
    11/04/2025 2.0 Added justification for missed sampling & tighter time limits GMP Enhancement QA Head
    See also  Elixir Department: SOP for Operation of Filter Press - V 2.0
    Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

    Post navigation

    Previous Post: Creating an SOP Violation Escalation Policy
    Next Post: Analytical Method Development: SOP for Dissolution Method for Delayed Release Tablets – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2026 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version